Included In This Lesson
Outline
What is the Generic Name
ALOGLIPTIN
What is the Trade Name for ALOGLIPTIN
Alogliptin
What is the Indication for ALOGLIPTIN
- 1 INDICATIONS AND USAGE Alogliptin tablets are a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1.1 , 14 ) Important Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1.1 ) 1.1 Monotherapy and Combination Therapy Alogliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14) ]. Important Limitations of Use Alogliptin tablets are not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources